Home - Chinese Journal of Cancer Research

2024 Impact Factor of CJCR: 6.3
Journal Citation Reports ™, Clarivate Analytics

Temporal trends, disease burden and attributable risk factors of stomach and colorectal cancers among 31 countries and territories in Western Pacific region, 2000−2021

Stomach cancer (SC) and colorectal cancer (CRC) present significant public health challenges because of their high incidence and mortality. According to the International Agency for Research on Cancer (IARC), more than 968,000 new cases and nearly 660,000 deaths of SC occurred in 2022, ranking the cancer as fifth in terms of both incidence and mortality worldwide. Among the six WHO regions, the Western Pacific region (WPR) suffered from the heaviest burdens of SC and CRC.

Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 2021

Data on the global, regional and national changes in the trends of colorectal cancer (CRC) are analyzed to understand the trends in its burden, in order to assist policymakers in allocating healthcare resources and developing prevention and control strategies. Referring to the latest data from the GBD 2021, this study quantifies the impact of different factors on the global, regional, and national burden of disease associated with CRC, and focuses on the differences in the burden of CRC across different SDI regions as well as across different age groups. This study was conducted to rationally allocate medical resources and optimize preventive strategies based on the analysis of the results.

Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images

Artificial intelligence has been widely applied in analysis of medical images, including computed tomography images, endoscopic images, histological images, and organoids images. In the current research, the performance of 14 convolutional neural network models was explored for classification and prediction of endoscopic images from human stomach. The purpose is to improve diagnostic accuracy and working efficiency. By training and comparison, EfficientNetB7 revealed the best performance on two-category of gastric cancer and benign lesions, gastric ulcer and ulcerated cancer, as well as early gastric cancer and non-gastric cancer. The EfficientNetB7 was also suitable for predicting the infection of Helicobacter pylori (Hp) and non-Hp infection (noHp). Notable, the InceptionV3 model was capable of predicting perigastric lymph nodes metastasis from endoscopic images.

IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer

Non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancers, with most patients presenting with advanced or metastatic disease. Lung cancer incidence is particularly high among Asians, who constitute approximately 50% of the global cases. This study reports the results from the phase III IMpower210 study, which compared the efficacy and safety of atezolizumab monotherapy with those of docetaxel in East Asian patients with advanced or metastatic NSCLC who had experienced disease progression with platinum-based chemotherapy. IMpower210 did not meet its primary efficacy endpoint of OS in the ITT EGFR-WT or overall ITT populations. Atezolizumab was comparatively more tolerable than docetaxel, with a lower incidence of grade 3/4 TRAEs.

Plant-based dietary patterns and risk of esophageal cancer: A prospective cohort study spanning 17 years

Plant-based diets have multiple health benefits for cancers; however, little is known about the association between plant-based dietary patterns and esophageal cancer (EC). This study presents an investigation of the prospective associations among three predefined indices of plant-based dietary patterns and the risk of EC. It performed endoscopic screening for 15,709 participants aged 40−69 years from two high-risk areas of China from January 2005 to December 2009 and followed the cohort until December 31, 2022. This study proves that a healthy plant-based dietary pattern was associated with a reduced risk of EC. Emphasizing the healthiness and quality of plant-based diets may be important for preventing the development of EC.

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

‹ ›

Vol 37, No 5 (Oct 2025)

Special Issue on Advances in Hematopoietic Stem Cell Transplantation for High-risk Hematologic Malignancies (II)

Review Article

Gut microbiota and acute graft-versus-host disease

Zhile Chen, Lin Li, Diange Jin, Yanmin Zhao, Florent Malard, He Huang, Yishan Ye, Mohamad Mohty

Pages: 657-666 HTML

Adapting measurable residual disease evaluation to clinical practice for patients with acute lymphoblastic leukemia who underwent allogeneic stem cell transplantation

Yulun Chen, Siqi Li, Xiaosu Zhao, Yingjun Chang

Pages: 667-685 HTML

Original Article

High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in China

Yuewen Wang, Yi Xia, Zhenyang Gu, Yu Chang, Lei Yang, Peipei Yang, Yanmin Zhao, Chunli Zhang, Na Wang, Shenmiao Yang, Yang Yang, Chuanhe Jiang, Leqing Cao, Daoxing Deng, Haiyang Lu, Fengrong Wang, Mingzhi Zhang, Yang Cao, Xiaoxia Hu, Ting Niu, Xiaodong Mo

Pages: 686-704 HTML

Can one scoring system fit all? Comparative validation of CAR-HEMATOTOX, ALL-HEMATOTOX, and eIPM for predicting immune effector cell-associated hematotoxicity following CAR-T therapy in hematologic malignancies

Aoran Zhang, Hao Zheng, Qiannan Shang, Xianying Yin, Yihan Yang, Ya Luo, Tong Su, Xuelin Dou, Ting Zhao, Xuying Pei, Zhuojun Liu, Jin Lu, Xiaohui Zhang, Xiaojun Huang, Xiaodong Mo, Meng Lv, Xiangyu Zhao

Pages: 705-717 HTML

Perspective

Allogeneic transplantation in adverse-risk acute myeloid leukemia: Challenges, strategies, and future directions

Jingtao Huang, Xinyi Wu, Gaoxiang Wang, Yang Cao, Xiaoxia Hu, on behalf of TROPHY working group

Pages: 718-736 HTML

Correspondence

Haploidentical donor vs. human leukocyte antigen-matched donor hematopoietic cell transplantation for elderly patients with hematologic malignancies: Inferior non-relapse mortality but comparable survival

Mengqi Xiang, Xiang Zhang, Mimi Xu, Yuqing Tu, Juan Shen, Xiaoli Li, Xiaojin Wu, Suning Chen, Ying Wang, Yue Han, Miao Miao, Aining Sun, Huiying Qiu, Yi Fan, Depei Wu, Jia Chen

Pages: 737-741 HTML

Review Article

Advances in integrating biomaterials with CAR-T cells for enhancing solid tumor therapy

Shuting Huang, Yan Zhao, Jie Shen

Pages: 742-758 HTML

Original Article

Global, regional, and national burden of thyroid cancer in working-age population: A systematic analysis for the Global Burden of Disease Study 2021

Tingting Zuo, He Li, Tianyi Li, Yuanjie Zheng, Bo Zhu, Wanqing Chen

Pages: 759-770 HTML

Clinical impact of [⁶⁸Ga]Ga-RM2 positron emission tomography imaging on staging and prognosis in estrogen receptor-positive breast cancer: A pilot study

Jin Ding, Huan Ma, Xiaoyi Guo, Futao Liu, Qing Xie, Yan Zhang, Zhi Yang, Deling Li, Guohong Song, Hua Zhu

Pages: 771-780 HTML

Longitudinal variability of CT imaging features for predicting pulmonary nodule invasiveness: A multicenter study

Jing Lu, Ci Song, Hai Xu, Jingyi Fan, Kefu Liu, Jie Chen, Junjie Kong, Wen Guo, Xinyuan Ge, Jiahao Zhang, Hongxia Ma, Qun Zhang, Hongbing Shen

Pages: 781-795 HTML

Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma

Wei Xia, Jiwei Liu, Ruo Chen, Junjie Feng, Lei Wu, Yize Wang, Xiaokun Wang, Chenghu Song, Wenjun Mao

Pages: 796-820 HTML

Impact of resection margin status on survival in gastric cancer: A retrospective cohort study

Whei Kyong Jung, Jane Chungyoon Kim, Hyun-Jae Lee, Kyo-Young Park, Sa-Hong Kim, Jeesun Kim, Yo-Seok Cho, Yun-Suhk Suh, Seong-Ho Kong, Do Joong Park, Hye Seung Lee, Han-Kwang Yang, Yoonjin Kwak, Hyuk-Joon Lee

Pages: 821-836 HTML

Comparison of short- and long-term outcomes of robotic vs. laparoscopic gastrectomy for clinical serosa-invasive gastric cancer: A multicenter cohort study

Hualong Zheng, Zhiwei Zheng, Honghong Zheng, Taiyuan Li, Linghua Wei, Li Zhang, Junjun She, Baoqing Jia, Xingan Qin, Shuangyi Ren, Hongliang Yao, Zhen Xue, Lingkang Zhang, Jiabin Wang, Changming Huang, Ping Li

Pages: 837-850 HTML

Plasma cell-free DNA methylation markers for detection and prognosis of gastric cancer: A case-control study

Yanan Wang, Longyang Jin, Weiyang He, Jiaxi Peng, Kailai Yin, Xuanhui Liu, Pengcheng Yu, Yi Wang, Zhehan Bao, Yuhang Xia, Fengming Zhang, Chun Song, Li Yuan, Yuying Wang, Lei Lian, Xiaodong Chen, Xiangdong Cheng

Pages: 851-864 HTML

HBV reactivation and its metabolomic profile after liver transplantation for hepatocellular carcinoma in non-alcoholic steatohepatitis

Jinyan Chen, Leyi Chen, Huigang Li, Zhihang Hu, Jianyong Zhuo, Xingzhu Chen, Ruijie Zhao, Chiyu He, Xiang Wu, Zhanyi Lin, Jiancai Sun, Rongsen Wang, Xuyong Wei, Shusen Zheng, Xiao Xu, Di Lu

Pages: 865-878 HTML

CSCO Guidelines

Updates of CSCO guidelines for colorectal cancer version 2025

Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

Pages: 297-302 HTML

CSCO guidelines for colorectal cancer version 2024: Updates and discussions

Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng

Pages: 233-239 HTML

CSCO guidelines for colorectal cancer version 2023: Updates and insights

Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan

Pages: 233-238 HTML

CSCO guidelines for colorectal cancer version 2022: Updates and discussions

Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan

Pages: 67-70 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)

Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology

Pages: 289-301 HTML

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan

Pages: 302-307 HTML

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 403-407 HTML

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Pages: 117-134 HTML

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

Pages: 197-232 HTML